Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis

The Journal of Steroid Biochemistry and Molecular Biology
M KudohH Shikama

Abstract

Estrogen deprivation therapy effectively prevents progress of endometriosis but the precise mechanism by which estrogen stimulates growth of endometriotic implants is still unknown. We examined effects of hypoestrogenic state induced by ovariectomy, gonadotropin-releasing hormone agonist (leuprolide) or aromatase inhibitor (YM511), on growth of experimental endometrial explant, a section of endometrium transplanted under the renal capsule, in rats. Ovariectomy gradually reduced the volume of endometrial explants for 21 days. YM511 (0.1 mg/kg) and leuprolide (1 mg/rat) completely reduced volume of endometrial explants but they differed widely in the onset of inhibitory action. YM511 prevented growth of explants on day 4 but leuprolide had no inhibitory effect until day 15. YM511 dose-dependently reduced volume of endometrial explants and its minimum effective dose was 0.04 mg/kg. Insulin-like growth factor-I (IGF-I) mRNA expression in endometrial explant and uterus was examined on day 4. YM511 decreased IGF-I expression in endometrial explant and uterus by 58% and 48%, respectively. Reductions of the extent of IGF-I expression by YM511 and ovariectomy were comparable. A significant correlation between the volume and IGF-I mRNA e...Continue Reading

References

Jan 1, 1978·The Journal of Clinical Endocrinology and Metabolism·C LongcopeS E Fineberg
Oct 1, 1976·Journal of Steroid Biochemistry·A M BrodieH J Brodie
Feb 1, 1992·American Journal of Obstetrics and Gynecology·R L Barbieri
Apr 1, 1990·Drugs·R L Barbieri
Dec 1, 1988·Clinical Obstetrics and Gynecology·A B Gerbie, J A Merrill
Nov 1, 1988·The Journal of Clinical Investigation·W N RomR G Crysal
Sep 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·M KudohT Fujikura
May 1, 1996·The Journal of Steroid Biochemistry and Molecular Biology·M KudohT Fujikura

❮ Previous
Next ❯

Citations

Oct 10, 2002·Fertility and Sterility·Mario VignaliPaola Viganò
Apr 17, 2002·Maturitas·R Druckmann, U D Rohr
Dec 20, 2005·Obstetrical & Gynecological Survey·Simone FerreroNicola Ragni
Jan 22, 2005·Annual Review of Medicine·David H Barlow, Stephen Kennedy
Nov 3, 2010·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Seyit Temel CeyhanIskender Baser
Mar 22, 2006·Expert Opinion on Investigational Drugs·Richard O ChlouberElizabeth A Pritts
Oct 8, 2004·Expert Opinion on Therapeutic Targets·Warren B Nothnick
Dec 3, 2008·Expert Opinion on Emerging Drugs·Sun-Wei Guo
Oct 30, 2010·European Journal of Obstetrics, Gynecology, and Reproductive Biology·João Nogueira NetoEduardo Schor
Apr 4, 2015·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Shawky Z A BadawyMartha A Wojtowycz
May 17, 2007·Acta Cirúrgica Brasileira·João Nogueira NetoLícia Kércia de Araújo Costa
Oct 24, 2007·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Francesca MiniciRosanna Apa
Feb 26, 2005·Annals of the New York Academy of Sciences·Thomas M D'HoogheJason M Mwenda
Jun 16, 2006·Human Reproduction Update·Ruth Grümmer
Jan 5, 2007·Gynecologic and Obstetric Investigation·Sun-Wei Guo, David L Olive
Nov 18, 1998·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·I Mayers, D Johnson
Jun 1, 2001·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·S N PiperJ Boldt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.